Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​







LATEST NEWS

Terumo Blood and Cell Technologies celebrates 60 years as a community-first Colorado company

Terumo BCT supports research about pregnancy with sickle cell disease

Terumo Blood and Cell Technologies names Mani Venkatesh the VP of Digital Transformation.

FDA Clears the Individualized Nomogram for Rika Plasma Donation System.

The Hidden Struggle: Confronting Sickle Cell Disease Health Inequalities. Read Terumo Blood and Cell Technologies' EU Sickle Cell Disease Manifesto.

World-leading CiRA to integrate Quantum Flex to develop automated iPS cell manufacturing. Learn more

BioCentriq® presents first public CAR-T expansion data from Terumo Blood and Cell Technologies’ Quantum Flex Cell Expansion System

Terumo Blood and Cell Technologies-sponsored panel publishes first-of-its-kind international consensus recommendations for pregnancy complications in patients with sickle cell disease

Hundreds of sickle cell patients to benefit from £1.5M technology investment

{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }} {{'SEARCH_MODAL_ENLABEL' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }} {{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}